NFSG
DCPH

Newbridge Financial Services Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Newbridge Financial Services Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-98
Closed -$1K – 1503
2022
Q2 		$1K Hold
98
– – ﹤0.01% 1325
2022
Q1 		$1K Hold
98
– – ﹤0.01% 1414
2021
Q4 		$1K Hold
98
– – ﹤0.01% 1382
2021
Q3 		$3K Hold
98
– – ﹤0.01% 1150
2021
Q2 		$4K Hold
98
– – ﹤0.01% 1190
2021
Q1 		$4K Buy
98
+51
+109% +$2.38K ﹤0.01% 1094
2020
Q4 		$3K Hold
47
– – ﹤0.01% 940
2020
Q3 		$2K Buy
+47
New +$2.3K ﹤0.01% 940

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Newbridge Financial Services Group's DCPH Position: Q3 2022 in Review

Newbridge Financial Services Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2022, closing a stake of 98 shares — an estimated $1K sold.

Newbridge Financial Services Group first reported a position in DCPH in Q3 2020 and held it in 8 quarters. The position peaked at $4K in Q2 2021. 150 funds tracked by Wall St. Rank hold DCPH as of Q3 2022.

  • Newbridge Financial Services Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Newbridge Financial Services Group sold 98 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • Newbridge Financial Services Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Newbridge Financial Services Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4K in Q2 2021.
  • 150 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Newbridge Financial Services Group's 13F filing for Q3 2022, filed 13 Oct 2022.